LIRAFIT DISPOPEN
By GLENMARK PHARMACEUTICALS LIMITED
Contains: LIRAGLUTIDE 6 MG
Product Summary
| Offer Price | ₹ 1727.2 |
|---|---|
| Your Savings | ₹ 304.80 (15% on MRP) |
About LIRAFIT DISPOPEN
- LIRAFIT DISPOPEN is a medication used for the treatment of type 2 diabetes mellitus and obesity. It belongs to a class of drugs called glucagon-like peptide-1 receptor agonists. LIRAFIT DISPOPEN helps regulate blood sugar levels by increasing insulin secretion, decreasing glucagon release, and slowing down the emptying of the stomach. In addition to its blood sugar-lowering effects, LIRAFIT DISPOPEN also promotes weight loss. It is administered as a once-daily injection and is available under the brand name Victoza for diabetes and Saxenda for obesity.
Uses of LIRAFIT DISPOPEN
- Helps in managing type 2 diabetes
- Aids in weight loss
- Controls blood sugar levels
- Reduces cardiovascular risks
How LIRAFIT DISPOPEN Works
- LIRAFIT DISPOPEN stimulates insulin secretion, suppresses glucagon release, and slows down gastric emptying, helping to regulate blood sugar levels and promote weight loss.
- LIRAFIT DISPOPEN is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the effects of the naturally occurring hormone GLP-1. By binding to GLP-1 receptors in the pancreas, LIRAFIT DISPOPEN enhances insulin secretion in response to elevated blood sugar levels, thereby lowering blood glucose. It also reduces the release of glucagon, a hormone that increases blood sugar levels, leading to further blood sugar control. LIRAFIT DISPOPEN slows down the emptying of the stomach, which helps regulate appetite and promotes satiety, leading to reduced food intake and weight loss. Additionally, it acts on the hypothalamus in the brain, affecting the central regulation of appetite and energy expenditure.
Dosage of LIRAFIT DISPOPEN
- Dosage for Children : LIRAFIT DISPOPEN is not recommended for use in children.
- Dosage for Adults : The initial recommended dose for adults is 0.6 mg once daily. The dosage can be increased to 1.2 mg or 1.8 mg based on individual response and tolerability.
Side Effects Of LIRAFIT DISPOPEN
- Nausea
- Vomiting
- Diarrhea
- Hypoglycemia
- Pancreatitis risk
How to Store LIRAFIT DISPOPEN
- Store in a refrigerator at 2-8°C (36-46°F)
- Do not freeze
- Protect from light
Frequently asked questions about LIRAFIT DISPOPEN
LIRAFIT DISPOPEN is used for managing type 2 diabetes and promoting weight loss in adults.
LIRAFIT DISPOPEN is administered as a once-daily subcutaneous injection.
LIRAFIT DISPOPEN can be used as a weight loss treatment in adults with obesity or overweight, even without diabetes.
Common side effects of LIRAFIT DISPOPEN include nausea, vomiting, diarrhea, and the risk of hypoglycemia.
LIRAFIT DISPOPEN should be used during pregnancy only if the potential benefits justify the potential risks to the fetus.
LIRAFIT DISPOPEN's effects on blood sugar control and weight loss may be noticeable within a few weeks of starting treatment.
LIRAFIT DISPOPEN is not addictive.
LIRAFIT DISPOPEN can be used in combination with other diabetes medications, as prescribed by a healthcare professional.
References related to LIRAFIT DISPOPEN
- Victoza® Non-Insulin | Victoza® (liraglutide) injection 1.2mg or 1.8mg. (2022). Retrieved June 15, 2023, from Victoza.com website: https://www.victoza.com/
- FDA. (2010). Victoza (liraglutide [rDNA origin] injection. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022341lbl.pdf
Chitrang Shah
Reviewed on 07 Nov 2022
Chitrang Shah
Reviewed on 07 Nov 2022
Had a good experience when I went for purchasing medicine. Appreciate the service
rensom christy
Reviewed on 06 Jan 2023
rensom christy
Reviewed on 06 Jan 2023
Super service
Mukesh Jain
Reviewed on 24 Jan 2024
Mukesh Jain
Reviewed on 24 Jan 2024
Proper medicine at big saving rate
Saurav
Reviewed on 11 Jan 2024
Saurav
Reviewed on 11 Jan 2024
Genuine product....
Venkataramanamurty Inguva
Reviewed on 15 Jul 2023
Venkataramanamurty Inguva
Reviewed on 15 Jul 2023
Tarif / Service is good